Literature DB >> 31640979

Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?

Keith S Kaye1, Twisha Patel2, George Drusano3.   

Abstract

Entities:  

Keywords:  MRSA; bacteremia; ceftaroline; daptomycin; vancomycin

Year:  2019        PMID： 31640979      PMCID： PMC6811404          DOI： 10.1128/AAC.01725-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience.

Authors:  Christopher J Destache; David J Guervil; Keith S Kaye
Journal:  Int J Antimicrob Agents       Date:  2019-01-31       Impact factor: 5.283

Review 2.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Clinical identifiers of complicated Staphylococcus aureus bacteremia.

Authors:  Vance G Fowler; Maren K Olsen; G Ralph Corey; Christopher W Woods; Christopher H Cabell; L Barth Reller; Allen C Cheng; Tara Dudley; Eugene Z Oddone
Journal:  Arch Intern Med       Date:  2003-09-22

4.  Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.

Authors:  George Sakoulas; Pamela A Moise; Anthony M Casapao; Poochit Nonejuie; Joshua Olson; Cheryl Y M Okumura; Michael J Rybak; Ravina Kullar; Abhay Dhand; Warren E Rose; Debra A Goff; Adam M Bressler; Yuman Lee; Joseph Pogliano; Scott Johns; Glenn W Kaatz; John R Ebright; Victor Nizet
Journal:  Clin Ther       Date:  2014-07-10       Impact factor: 3.393

5.  Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology.

Authors:  Sabrina Müller; Andrea J Wolf; Iliyan D Iliev; Bethany L Berg; David M Underhill; George Y Liu
Journal:  Cell Host Microbe       Date:  2015-11-11       Impact factor: 21.023

6.  Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.

Authors:  Shelley S Magill; Erin O'Leary; Sarah J Janelle; Deborah L Thompson; Ghinwa Dumyati; Joelle Nadle; Lucy E Wilson; Marion A Kainer; Ruth Lynfield; Samantha Greissman; Susan M Ray; Zintars Beldavs; Cindy Gross; Wendy Bamberg; Marla Sievers; Cathleen Concannon; Nicolai Buhr; Linn Warnke; Meghan Maloney; Valerie Ocampo; Janet Brooks; Tolulope Oyewumi; Shamima Sharmin; Katherine Richards; Jean Rainbow; Monika Samper; Emily B Hancock; Denise Leaptrot; Eileen Scalise; Farzana Badrun; Ruby Phelps; Jonathan R Edwards
Journal:  N Engl J Med       Date:  2018-11-01       Impact factor: 91.245

7.  Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Matthew Geriak; Fadi Haddad; Khulood Rizvi; Warren Rose; Ravina Kullar; Kerry LaPlante; Marie Yu; Logan Vasina; Krista Ouellette; Marcus Zervos; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.